Association of a Single-Nucleotide Variant rs11100494 of the <i>NPY5R</i> Gene with Antipsychotic-Induced Metabolic Disorders

Association of a Single-Nucleotide Variant rs11100494 of the <i>NPY5R</i> Gene with Antipsychotic-Induced Metabolic Disorders

Background: The usage of antipsychotics (APs) is the most robust and scientifically based approach in the treatment of schizophrenia spectrum disorders (SSDs). The efficiency of APs is based on a range of target receptors of the central nervous system (CNS): serotoninergic, dopaminergic, adrenergic,...

Full description

Bibliographic Details
Main Authors: Vera S. Dobrodeeva, Natalia A. Shnayder, Maxim A. Novitsky, Azat R. Asadullin, Elena E. Vaiman, Marina M. Petrova, Oleg V. Limankin, Nikolay G. Neznanov, Natalia P. Garganeeva, Regina F. Nasyrova
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Pharmaceutics
Subjects:
pharmacogenetics
schizophrenia
NPYR
neuropeptide Y receptor
antipsychotic-induced weight gain
adverse drug reactions
Online Access:https://www.mdpi.com/1999-4923/14/2/222

Internet

https://www.mdpi.com/1999-4923/14/2/222

Similar Items